Logo image of NNE

NANO NUCLEAR ENERGY INC (NNE) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:NNE - US63010H1086 - Common Stock

34.659 USD
+2.24 (+6.91%)
Last: 1/14/2026, 3:15:06 PM
Fundamental Rating

3

NNE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 91 industry peers in the Electrical Equipment industry. No worries on liquidiy or solvency for NNE as it has an excellent financial health rating, but there are worries on the profitability. NNE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year NNE has reported negative net income.
  • In the past year NNE has reported a negative cash flow from operations.
NNE Yearly Net Income VS EBIT VS OCF VS FCFNNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 -10M -20M -30M -40M

1.2 Ratios

  • NNE has a Return On Assets (-17.52%) which is comparable to the rest of the industry.
  • With a Return On Equity value of -18.00%, NNE perfoms like the industry average, outperforming 59.34% of the companies in the same industry.
Industry RankSector Rank
ROA -17.52%
ROE -18%
ROIC N/A
ROA(3y)-44.28%
ROA(5y)N/A
ROE(3y)-46.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NNE Yearly ROA, ROE, ROICNNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NNE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NNE Yearly Profit, Operating, Gross MarginsNNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025

More info and screens

8

2. Health

2.1 Basic Checks

  • NNE has more shares outstanding than it did 1 year ago.
  • NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
NNE Yearly Shares OutstandingNNE Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M
NNE Yearly Total Debt VS Total AssetsNNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • NNE has an Altman-Z score of 160.01. This indicates that NNE is financially healthy and has little risk of bankruptcy at the moment.
  • NNE's Altman-Z score of 160.01 is amongst the best of the industry. NNE outperforms 100.00% of its industry peers.
  • NNE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 160.01
ROIC/WACCN/A
WACCN/A
NNE Yearly LT Debt VS Equity VS FCFNNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 53.48 indicates that NNE has no problem at all paying its short term obligations.
  • NNE has a better Current ratio (53.48) than 100.00% of its industry peers.
  • A Quick Ratio of 53.48 indicates that NNE has no problem at all paying its short term obligations.
  • NNE's Quick ratio of 53.48 is amongst the best of the industry. NNE outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 53.48
Quick Ratio 53.48
NNE Yearly Current Assets VS Current LiabilitesNNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

0

3. Growth

3.1 Past

  • NNE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -187.04%.
EPS 1Y (TTM)-187.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, NNE will show a very negative growth in Earnings Per Share. The EPS will decrease by -26.14% on average per year.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-19.08%
EPS Next 2Y-21.51%
EPS Next 3Y-14.89%
EPS Next 5Y-26.14%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NNE Yearly Revenue VS EstimatesNNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B
NNE Yearly EPS VS EstimatesNNE Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NNE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NNE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NNE Price Earnings VS Forward Price EarningsNNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NNE Per share dataNNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

  • NNE's earnings are expected to decrease with -14.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.51%
EPS Next 3Y-14.89%

More info and screens

0

5. Dividend

5.1 Amount

  • NNE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

NANO NUCLEAR ENERGY INC

NASDAQ:NNE (1/14/2026, 3:15:06 PM)

34.659

+2.24 (+6.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)12-18
Earnings (Next)02-12
Inst Owners37.47%
Inst Owner Change0%
Ins Owners1.32%
Ins Owner Change-0.16%
Market Cap1.74B
Revenue(TTM)N/A
Net Income(TTM)-40.07M
Analysts77.5
Price Target37.99 (9.61%)
Short Float %31.86%
Short Ratio5.5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.59%
Min EPS beat(2)12.35%
Max EPS beat(2)38.82%
EPS beat(4)3
Avg EPS beat(4)-109.1%
Min EPS beat(4)-527.06%
Max EPS beat(4)39.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.47%
EPS NQ rev (1m)14.28%
EPS NQ rev (3m)14.28%
EPS NY rev (1m)3.58%
EPS NY rev (3m)3.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 7.8
P/tB 8.13
EV/EBITDA N/A
EPS(TTM)-1.05
EYN/A
EPS(NY)-1.25
Fwd EYN/A
FCF(TTM)-0.74
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0
BVpS4.45
TBVpS4.26
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.52%
ROE -18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-44.28%
ROA(5y)N/A
ROE(3y)-46.43%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 4933.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 53.48
Quick Ratio 53.48
Altman-Z 160.01
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-187.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-95.88%
EPS Next Y-19.08%
EPS Next 2Y-21.51%
EPS Next 3Y-14.89%
EPS Next 5Y-26.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-339.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-265.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-131.82%
OCF growth 3YN/A
OCF growth 5YN/A

NANO NUCLEAR ENERGY INC / NNE FAQ

Can you provide the ChartMill fundamental rating for NANO NUCLEAR ENERGY INC?

ChartMill assigns a fundamental rating of 3 / 10 to NNE.


What is the valuation status for NNE stock?

ChartMill assigns a valuation rating of 0 / 10 to NANO NUCLEAR ENERGY INC (NNE). This can be considered as Overvalued.


Can you provide the profitability details for NANO NUCLEAR ENERGY INC?

NANO NUCLEAR ENERGY INC (NNE) has a profitability rating of 1 / 10.